US EditionJury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
Two women awarded $40 million after a jury found Johnson & Johnson concealed decades of asbestos risk in talc baby powder linked to ovarian cancer.
- A jury awarded $40 million to two cancer patients who claimed Johnson & Johnson's talcum powder caused their ovarian cancer.
- Internal J&J documents from the 1970s showed the company knew its baby powder contained asbestos and put public health at risk, according to testimony.
- Medical experts testified that frequent genital talc use increases ovarian cancer risk by at least 50%, potentially doubling with long-term use.
44 Articles
44 Articles
Pharmaceutical giant Johnson & Johnson has been ordered to pay $40 million in damages to two women who claim the company's baby powder caused their cancer, several media outlets report.
Pharmaceutical giant Johnson & Johnson has been ordered to pay $40 million in damages to two women who claim the company's baby powder caused their cancer, several media outlets report.
The Associated Press - A Los Angeles jury awarded $40 million to two women who alleged that talc made by Johnson & Johnson caused them to develop ovarian cancer. The personal care company said it will appeal the verdict on liability and compensatory damages. Friday's ruling is the latest development in a protracted legal battle over allegations that Johnson's baby powder and Shower to Shower body powder were linked to ovarian cancer and mesothel…
Associated Press News
Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
A Los Angeles jury has awarded $40 million to two women who claim Johnson & Johnson's talcum powder caused their ovarian cancer. The company plans to appeal the verdict.
Coverage Details
Bias Distribution
- 43% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
